PNC-27 Peptide

One of the most promising new treatments for cancer is the research peptide PNC-27, an anti-cancer peptide designed to block HDM-2’s interaction with the p53 tumour suppressor protein. In addition, Membranolysis is shown to be an important mechanism by which it targets cancer cells and kills them (destruction of the cell membrane). However, this research peptide for scientific investigations is not approved by the FDA for human consumption.